Biotech firms show interest in developing antibiotics

05/17/2011 | Bloomberg

Biotech companies are increasing research into antibiotics, which large drugmakers are less frequently pursuing because of a lack of revenue opportunities, as strains of drug-resistant bacteria begin to emerge. One such company is Optimer Pharmaceuticals, which expects to get FDA approval by the end of the month for Dificid, an antibiotic against stomach infection.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ